{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:15:06Z","timestamp":1792091706078,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003451","name":"UPV\/EHU","doi-asserted-by":"crossref","award":["GIU15\/36"],"award-info":[{"award-number":["GIU15\/36"]}],"id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003451","name":"UPV\/EHU","doi-asserted-by":"crossref","award":["UFI11\/25"],"award-info":[{"award-number":["UFI11\/25"]}],"id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ijantimicag.2017.06.009","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T07:16:09Z","timestamp":1498720569000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pathobiology of Lomentospora prolificans : could this species serve as a model of primary antifungal resistance?"],"prefix":"10.1016","volume":"51","author":[{"given":"Aize","family":"Pellon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andoni","family":"Ramirez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idoia","family":"Buldain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitziber","family":"Antoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Martin\u2013Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitor","family":"Rementeria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando L.","family":"Hernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0010","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0015","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1126\/science.aaa6097","article-title":"Infectious disease. How to bolster the antifungal pipeline","volume":"347","author":"Denning","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0020","series-title":"How common are fungal diseases?","author":"The Fungal Infection Trust","year":"2016"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fmed.2016.00011","article-title":"Emerging threats in antifungal-resistant fungal pathogens","volume":"3","author":"Sanglard","year":"2016","journal-title":"Front Med"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/myc.12469","article-title":"Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus","volume":"59","author":"Gon\u00e7alves","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/CMR.00039-07","article-title":"Infections caused by Scedosporium spp","volume":"21","author":"Cortez","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0040","doi-asserted-by":"crossref","first-page":"E158","DOI":"10.1086\/320521","article-title":"Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990\u20131999","volume":"32","author":"Idigoras","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/13693780802524506","article-title":"Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases","volume":"47","author":"Rodriguez-Tudela","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0050","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/AAC.05910-11","article-title":"Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species","volume":"56","author":"Lackner","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0055","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.01388-07","article-title":"Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients","volume":"52","author":"Troke","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12465","article-title":"ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others","volume":"20","author":"Tortorano","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0065","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/AAC.44.2.470-472.2000","article-title":"In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans","volume":"44","author":"Meletiadis","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/AAC.47.1.106-117.2003","article-title":"In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates","volume":"47","author":"Meletiadis","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0075","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1128\/AAC.49.12.5157-5159.2005","article-title":"Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani","volume":"49","author":"Heyn","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0080","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.49.8.3498-3500.2005","article-title":"In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp","volume":"49","author":"Yustes","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0085","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1128\/AAC.01160-07","article-title":"In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans","volume":"52","author":"Cuenca-Estrella","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/AAC.50.2.414-421.2006","article-title":"Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis","volume":"50","author":"Widmer","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0095","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/jac\/dkt282","article-title":"In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens","volume":"68","author":"Biswas","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1099\/jmm.0.000019","article-title":"In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp","volume":"64","author":"Compain","year":"2015","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0105","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/597772","article-title":"Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report","volume":"48","author":"Kesson","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0110","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/myc.12199","article-title":"Disseminated Scedosporium prolificans infection in an \u2018extensive metaboliser\u2019: navigating the minefield of drug interactions and pharmacogenomics","volume":"57","author":"Trubiano","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jac\/49.3.525","article-title":"Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans","volume":"49","author":"Ortoneda","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0120","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1128\/AAC.49.12.5139-5141.2005","article-title":"Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis","volume":"49","author":"Bocanegra","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0125","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/AAC.01477-08","article-title":"Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans","volume":"53","author":"Rodriguez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0130","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/AAC.47.6.1948-1951.2003","article-title":"Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits","volume":"47","author":"Capilla","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/13693780412331271072","article-title":"Interferon gamma and granulocyte\u2013macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: comparison with Aspergillus spp","volume":"43","author":"Gil-Lamaignere","year":"2005","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2004.07.016","article-title":"Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp","volume":"31","author":"Winn","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0145","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/AAC.46.7.2234-2237.2002","article-title":"Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum","volume":"46","author":"Gil-Lamaignere","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0150","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jac\/dkf198","article-title":"Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum","volume":"50","author":"Gil-Lamaignere","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/clinids\/23.1.192","article-title":"Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor","volume":"23","author":"Bouza","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0160","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.05414-11","article-title":"Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods","volume":"56","author":"Castanheira","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/myc.12022","article-title":"In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis","volume":"56","author":"Schemuth","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0170","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1128\/AAC.00957-15","article-title":"N\u2013Chlorotaurine exhibits fungicidal activity against therapy-refractory Scedosporium species and Lomentospora prolificans","volume":"59","author":"Lackner","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0175","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1128\/AAC.00234-15","article-title":"Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates","volume":"59","author":"Lamoth","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0180","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/jac\/dku549","article-title":"Antifungal activity of compounds targeting the Hsp90-calcineurin pathway against various mould species","volume":"70","author":"Lamoth","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0185","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S1473-3099(16)30323-1","article-title":"Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections","volume":"17","author":"Abdelmohsen","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0190","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fmicb.2017.00336","article-title":"Antifungal therapy for systemic mycosis and the nanobiotechnology era: improving efficacy, biodistribution and toxicity","volume":"8","author":"Souza","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0195","doi-asserted-by":"crossref","first-page":"e0174885","DOI":"10.1371\/journal.pone.0174885","article-title":"Molecular and cellular responses of the pathogenic fungus Lomentospora prolificans to the antifungal drug voriconazole","volume":"12","author":"Pellon","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0200","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1128\/AAC.01811-10","article-title":"New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species","volume":"55","author":"Johnson","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrmicro1835","article-title":"The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype","volume":"6","author":"Cowen","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0210","first-page":"310","article-title":"Heat shock protein 90 (Hsp90): a novel antifungal target against Aspergillus fumigatus","volume":"42","author":"Lamoth","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0215","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/1462-2920.12470","article-title":"Identifying the emerging human pathogen Scedosporium prolificans by using a species-specific monoclonal antibody that binds to the melanin biosynthetic enzyme tetrahydroxynaphthalene reductase","volume":"17","author":"Thornton","year":"2015","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0220","doi-asserted-by":"crossref","first-page":"e1000040","DOI":"10.1371\/journal.ppat.1000040","article-title":"Stimulation of chitin synthesis rescues Candida albicans from echinocandins","volume":"4","author":"Walker","year":"2008","journal-title":"PLoS Pathog"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2017.06.009_bib0225","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2017.06.009_bib0230","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1080\/13693780400029023","article-title":"Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin","volume":"43","author":"Gardiner","year":"2005","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2017.06.009_bib0235","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/AAC.00917-07","article-title":"A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus","volume":"51","author":"Rocha","year":"2007","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T01:21:45Z","timestamp":1589764905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917302194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0924857917302194"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.06.009","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathobiology of Lomentospora prolificans: could this species serve as a model of primary antifungal resistance?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}